Adam Ware,
MD
Languages Spoken: English, Spanish
Adam Ware, MD is a Pediatric Cardiologist at the University of Utah and Primary Children’s Medical Center. Dr. Ware specializes in the care of children and adolescents with congenital heart disease, cholesterol disorders, and other genetic and acquired heart diseases.
Dr. Ware completed his medical education at the Mayo Clinic and subsequently completed a pediatrics residency and pediatric cardiology fellowship at the University of Utah and Primary Children’s Hospital. As a native of a rural Utah community, Dr. Ware is passionate about outreach and has several clinics throughout the state.
Clinical Locations
Primary Children's Hospital
801-662-1000
Specialties
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Assistant Professor (Clinical) |
| Academic Divisions | Pediatric Cardiology |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Pediatrics (Sub: Pediatric Cardiology) |
Adam Ware, MD is an Assistant Professor in the Division of Pediatric Cardiology at the University of Utah and Primary Children’s Hospital. He joined the division in 2016. Dr. Ware completed his medical education at the Mayo Clinic in Rochester, Minnesota and subsequently completed a pediatrics residency and pediatric cardiology fellowship at the University of Utah and Primary Children’s Hospital. Dr. Ware’s primary clinical focus is the care of patients with congenital and acquired heart disease. He has a particular interest in patients with genetic and acquired lipid disorders.
Dr. Ware’s research efforts will focus on patients with lipid disorders including the role of statin therapy, the role of universal screening, and outcomes of children with congenital heart disease and lipid disorders. He is currently a co-principle investigator for a Pediatric Heart Network study evaluating the effectiveness of statin therapy for children with dyslipidemia related to obesity. Additionally, he has worked on identifying the prevalence of risk factors for coronary artery disease in children with congenital heart disease.
Dr. Ware has additional research experience including investigating the outcome and cost of infective endocarditis in children with heart disease, a pathologic evaluation of sinus node location in children with heterotaxy syndrome, a clinical and pathologic comparison of patients with neonatal and classic Marfan syndrome, and the role of evaluating donor specific antibody in children following heart transplant.
Academic Locations
Eccles Primary Children’s Outpatient Services Building
801-213-3599
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Assistant Professor (Clinical) |
| Academic Divisions | Pediatric Cardiology |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Pediatrics (Sub: Pediatric Cardiology) |
Education History
| Fellowship | Primary Children’s Hospital/University of Utah Pediatric Cardiology Fellow |
| Residency | Primary Children’s Hospital/University of Utah General Pediatrics Resident |
| Professional Medical | Mayo Clinic College of Medicine Medicine M.D. |
| Undergraduate | Westminster College Biology; Minors: Chemistry, Spanish B.S. |
Publications - Journal Articles
Journal Article
- Ware AL, Malmberg E, Delgado JC, Hammond ME, Miller DV, Stehlik J, Kfoury A, Revelo MP, Eckhauser A, Everitt MD (2016). The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children. J Heart Lung Transplant, 35(2), 179-85.
- Ware AL, Tani LY, Weng HY, Wilkes J, Menon SC (2014). Resource utilization and outcomes of infective endocarditis in children. J Pediatr, 165(4), 807-12.e1.
- Ware AL, Miller DV, Porter CB, Edwards WD (2012). Characterization of atrial morphology and sinus node morphology in heterotaxy syndrome: an autopsy-based study of 41 cases (1950-2008). Cardiovasc Pathol, 21(5), 421-7.
- Ware AL, Suri RM, Stulak JM, Sundt TM 3rd, Schaff HV (2011). Left atrial ganglion ablation as an adjunct to atrial fibrillation surgery in valvular heart disease. Ann Thorac Surg, 91(1), 97-102.